BRIEF—Shareholders approve Novozymes and Chr Hansen merger

Novozymes and Chr Hansen held their respective extraordinary general meetings, and the shareholders of both companies approved the proposed combination.

He planned merger of the two Danish companies was first announced in December last year, at which time financial terms were not disclosed, nor are they now.

Novo Holdings, the largest shareholder in both Novozymes and Chr Hansen, has previously affirmed its confidence in the two companies being a perfect match.

Following completion of the combination, the new company will be science-based, with powerful capabilities and commercial excellence to develop biological solutions that will enable healthier lives, transform food systems, and accelerate towards a climate neutral society.

The approval from the shareholders of both Novozymes and Chr Hansen marks an important milestone towards uniting the two companies, they said.